{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:13:23Z","timestamp":1791296003152,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2866,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1038\/sj.ki.5002695","type":"journal-article","created":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T08:56:35Z","timestamp":1200387395000},"page":"251-253","source":"Crossref","is-referenced-by-count":28,"title":["Calcium, cyclic AMP, and MAP kinases: Dysregulation in polycystic kidney disease"],"prefix":"10.1016","volume":"73","author":[{"suffix":"Jr","given":"B.D.","family":"Cowley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5002695_bb0010","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1681\/ASN.2005060645","article-title":"Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells","volume":"17","author":"Yamaguchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002695_bb0015","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5002695_bb0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.ki.5002629","article-title":"Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy\/+ rat","volume":"73","author":"Nagao","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002695_bb0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ncpneph0070","article-title":"Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases","volume":"2","author":"Torres","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1038\/sj.ki.5002695_bb0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ndt\/12.1.25","article-title":"Calcium channel blockers: what they can and what they can't do","volume":"12","author":"Mene","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002695_bb0035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.RES.0000256155.31133.49","article-title":"Ca2+ channel subtypes and pharmacology in the kidney","volume":"100","author":"Hayashi","year":"2007","journal-title":"Circ Res"},{"key":"10.1038\/sj.ki.5002695_bb0040","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1113\/jphysiol.2003.043349","article-title":"Epithelial Ca2+ entry channels: transcellular Ca2+ transport and beyond","volume":"551","author":"Peng","year":"2003","journal-title":"J Physiol"},{"key":"10.1038\/sj.ki.5002695_bb0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1440-1797.2006.00535.x","article-title":"Optimal care of autosomal dominant polycystic kidney disease patients","volume":"11","author":"Schrier","year":"2006","journal-title":"Nephrology"},{"key":"10.1038\/sj.ki.5002695_bb0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1523-1755.2005.00077.x","article-title":"The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease","volume":"67","author":"Jafar","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002695_bb0055","doi-asserted-by":"crossref","first-page":"c18","DOI":"10.1159\/000081790","article-title":"Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease","volume":"99","author":"Nutahara","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/sj.ki.5002695_bb0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/oxfordjournals.qjmed.a030139","article-title":"Calcium channel blockers versus ACE inhibitors as antihypertensives in polycystic kidney disease","volume":"89","author":"Kanno","year":"1996","journal-title":"Q J Med"},{"key":"10.1038\/sj.ki.5002695_bb0065","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/ndt\/gfg417","article-title":"No effect of enalapril on progression in autosomal dominant polycystic kidney disease","volume":"18","author":"van Dijk","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002695_bb0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(03)12229-5","article-title":"Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial","volume":"361","author":"Nakao","year":"2003","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5002695_bb0075","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2165\/00003495-200464120-00002","article-title":"Recent advances in understanding the pathogenesis of polycystic kidney disease: therapeutic implications","volume":"64","author":"Cowley","year":"2004","journal-title":"Drugs"},{"key":"10.1038\/sj.ki.5002695_bb0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ki.1997.2","article-title":"Understanding the nature of renal disease progression","volume":"51","author":"Remuzzi","year":"1997","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815529931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815529931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T11:09:48Z","timestamp":1626865788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815529931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0085253815529931"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5002695","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}